Ramelteon and Placebo

DRUG2 trials

Sponsors

Takeda

Conditions

COPDChronic Obstructive Pulmonary Disease

Phase 2

Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease

CompletedNCT00672802

TakedaChronic Obstructive Pulmonary Disease, COPD

Start: 2003-08-31End: 2004-03-31Updated: 2012-02-28

Phase 4

Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease

CompletedNCT00316992

TakedaChronic Obstructive Pulmonary Disease

Start: 2006-04-30End: 2006-11-30Updated: 2010-06-02